Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/23/2010US20100323998 Topical composition containing the combination of mupirocin and beclomethasone
12/23/2010US20100323997 Novel uses
12/23/2010US20100323996 Means and methods of controlling commensales
12/23/2010US20100323995 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
12/23/2010US20100323994 Substituted imidazopyridazines useful as kinase inhibitors
12/23/2010US20100323993 Uses of pentamidine and related compounds
12/23/2010US20100323992 Pharmaceutical compositions for preventing and treating eye pathologies
12/23/2010US20100323991 Methods and products for treatment of diseases
12/23/2010US20100323990 Ship 1 modulator prodrugs
12/23/2010US20100323989 Pharmaceutical combinations useful for treating hcv
12/23/2010US20100323988 Solid citrate and tartrate salts of dpp-iv inhibitors
12/23/2010US20100323987 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
12/23/2010US20100323986 Compositions and methods for modulation of vascular structure and/or function
12/23/2010US20100323985 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
12/23/2010US20100323984 Cosmetic oral and/or parenteral use of glucosamine optionally in combination with at least one polyphenol compound, and corresponding composition
12/23/2010US20100323983 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof, and uses thereof
12/23/2010US20100323982 Food composition for prodromal dementia patients
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323980 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
12/23/2010US20100323979 Methods and compositions for inhibiting proliferation of aneuploid cells
12/23/2010US20100323978 Non-aqueous oil delivery system for ophthalmic drugs
12/23/2010US20100323977 Mucoadhesive nanoparticles for cancer treatment
12/23/2010US20100323976 Novel anti-inflammatory pro-drugs
12/23/2010US20100323967 RNA Antagonist Compounds for the Modulation of MCL-1
12/23/2010US20100323965 Thrombopoietin Mimetics
12/23/2010US20100323963 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
12/23/2010US20100323959 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323958 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323952 Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections
12/23/2010US20100323046 Novel uses of hibiscus, in particular pharmaceutical uses
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323036 Nitric Oxide Therapies
12/23/2010US20100323034 Method for determination of sensitivity to anti-cancer agent
12/23/2010US20100323033 Cancer sensitizer comprising chlorogenic acid
12/23/2010US20100323030 Composition with Anti-Inflammatory, Protein Synthesizing, Enzyme Deficiency Activating Genetic Therapy and Anti-Cancer Activity and Methods of Use
12/23/2010US20100323028 Method and composition for treating pulmonary hemorrhage
12/23/2010US20100323026 Sustained release preparation for tissue regeneration therapy
12/23/2010US20100323020 Stable nanoparticulate drug suspension
12/23/2010US20100323019 Microparticles for the treatment of disease
12/23/2010US20100323018 Branched DNA/RNA monomers and uses thereof
12/23/2010US20100323017 Escitalopram and Solid Pharmaceutical Composition Comprising the Same
12/23/2010US20100323016 Modified release formulation and methods of use
12/23/2010US20100323015 Modified release formulation and methods of use
12/23/2010US20100323014 Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
12/23/2010US20100323012 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and Diuretics
12/23/2010US20100323011 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
12/23/2010US20100323010 Formulation and process for drug loaded cores
12/23/2010US20100323008 Solid dosage form comprising a fibrate
12/23/2010US20100323006 Pharmaceutical solid preparation comprising benzazepines and production method thereof
12/23/2010US20100323005 Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen
12/23/2010US20100323003 Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines
12/23/2010US20100323002 Inhibition of melanogenesis and melanoma metastasis with p-amino benzoic acid (paba)
12/23/2010US20100323001 In Vivo Delivery Of Double Stranded RNA To a Target Cell
12/23/2010US20100323000 Method and process for preparing cardiolipin
12/23/2010US20100322999 Fentanyl-containing patch for external use
12/23/2010US20100322997 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same
12/23/2010US20100322993 Injectable biocompatible composition
12/23/2010US20100322992 Anti-Proliferative And Anti-Inflammatory Agent Combination For Treatment Of Vascular Disorders With An Implantable Medical Device
12/23/2010US20100322991 Honokiol analogs and their use in treating cancers
12/23/2010US20100322989 Hydrophilic skin cleaning cloth
12/23/2010US20100322985 Effervescent compositions
12/23/2010US20100322982 Alloplastic injectable dermal filler and methods of use thereof
12/23/2010US20100322980 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
12/23/2010US20100322979 Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles
12/23/2010US20100322978 Medical composition
12/23/2010US20100322971 Method for producing vaccinal viral strain of a virus of the reoviridae family
12/23/2010US20100322965 Viral vaccine vectors
12/23/2010US20100322961 Intranasal Drug Delivery System
12/23/2010US20100322958 Modified saccharides
12/23/2010US20100322949 Methods for diagnosing and treating astrocytomas
12/23/2010US20100322942 Therapeutic and prophylactic methods for neuromuscular disorders
12/23/2010US20100322928 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
12/23/2010US20100322926 Methods of using cadherin 11 (cdh11) antagonists
12/23/2010US20100322923 Medical Uses of Glucans
12/23/2010US20100322918 Diffusion enhancing compounds and their use alone or with thrombolytics
12/23/2010US20100322908 Compositions and methods for augmentation and regeneration of living tissue in a subject
12/23/2010US20100322907 Expansion of Hematopoietic Stem Cells
12/23/2010US20100322902 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010US20100322900 Treatment of multiple sclerosis with laquinimod
12/23/2010US20100322897 Characterization of il-17f and il-17r interactions
12/23/2010US20100322895 T cell depleting compositions useful for treating cancer
12/23/2010US20100322894 Combination Therapies for Treating Type 1 Diabetes
12/23/2010US20100322884 Method and composition for transdermal drug delivery
12/23/2010US20100322881 Uvb filter based on ascorbic acid derivatives
12/23/2010US20100322880 Uva filters based on ascorbic acid derivatives
12/23/2010US20100322875 Silicone scar treatment preparation
12/23/2010US20100322870 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
12/23/2010US20100322869 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
12/23/2010US20100322862 Methods and compositions using peptides and proteins with c-terminal elements
12/23/2010US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322852 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010CA2803059A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
12/23/2010CA2767895A1 Opsin-binding ligands, compositions and methods of use
12/23/2010CA2765876A1 Compositions and methods for treating amyotrophic lateral sclerosis
12/23/2010CA2765847A1 Prophylactic and/or therapeutic agent for dysmenorrhea
12/23/2010CA2765822A1 Novel gpr 119 agonists
12/23/2010CA2765792A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
12/23/2010CA2765770A1 Agents and uses thereof
1 ... 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 ... 7860